Skip to main content
Clinical Trials/JPRN-UMIN000050495
JPRN-UMIN000050495
Recruiting
N/A

Monitoring study with electronic patient-reported outcome for advanced soft tissue sarcoma case during the administration of anti-tumoral drugs -JMOG066- - ePRO monitoring for advanced soft tissue sarcoma undergoing anti-tumoral drugs

Japanese Musculoskeletal Oncology Group0 sites150 target enrollmentMarch 31, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
advanced soft tissue sarcoma
Sponsor
Japanese Musculoskeletal Oncology Group
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2023
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japanese Musculoskeletal Oncology Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who have difficulty in answering ePRO due to either dementia, psychiatric disorder, or others 2\) Patients that the principal investigator judged incorporation into research is inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials